Stocks Health care AEMD
NASDAQ · Health careAethlon Medical Inc (AEMD)
It posted a net loss of $6.9M. In fiscal 2026 capital spending exceeded operating cash flow by $7M. At June 30, 2026 it held $4.9M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
Key facts about Aethlon Medical Inc
- Net worth
- Aethlon Medical Inc has a market value (market cap) of $3.9M at the latest share price, and shareholders' equity of $5.2M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2024 revenue was $0 (-100.0% year on year), with a net loss of $12.2M.
- Cash flow
- In fiscal 2026 operations used $7M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 13, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Aethlon Medical Inc's next report is expected around November 13, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
What Aethlon Medical Inc does
Aethlon Medical Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker AEMD.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2026 | n/a | -$7.2M | -$10.61 | -$7M |
| 2025 | n/a | -$13.4M | -$85.77 | -$7.6M |
| 2024 | $0 | -$12.2M | -$388.56 | -$10.4M |
| 2023 | $574.2K | -$12M | -$468.52 | -$11.4M |
| 2022 | $294.2K | -$10.4M | -$563.81 | -$10.1M |
| 2021 | $659.1K | -$7.9M | -$516.16 | -$6.8M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Aethlon Medical Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 5, 2026Shareholder vote results 8-K/A
- October 1, 2026Executive or director change8-KAethlon Medical stockholders approved all proposals at the annual meeting, including an expansion of authorized shares and an equity plan amendment.
- September 17, 2026Form 425 filing 425
- September 17, 2026Change in control8-KAethlon Medical agreed to merge with North Immunology in an all-stock transaction supported by an approximately $180 million private placement.
- September 15, 2026
- September 4, 2026Additional proxy material DEFA14A
- September 1, 2026Proxy statement DEF 14A
- August 31, 2026Other event 8-K
- August 21, 2026Preliminary proxy statement PRE 14A
- August 13, 2026
Insider trades
What the people running Aethlon Medical Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| June 30, 2026 | Broenniman Edward GDirector | Shares withheld for tax | 1,091 | $894.6 |
| June 30, 2026 | Gikakis NicolasDirector | Shares withheld for tax | 2,182 | $1.8K |
| June 30, 2026 | Shah ChetanDirector | Shares withheld for tax | 2,182 | $1.8K |
| April 17, 2026 | Broenniman Edward GDirector | Received as pay | 21,815 | $50K |
| April 17, 2026 | Gikakis NicolasDirector | Received as pay | 21,815 | $50K |
| April 17, 2026 | Shah ChetanDirector | Received as pay | 21,815 | $50K |
| April 17, 2026 | Rossetti AngelaDirector | Received as pay | 21,815 | $50K |
| March 31, 2026 | Broenniman Edward GDirector | Shares withheld for tax | 89 | $194.9 |
Who owns AEMD
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
Largest institutional holders
Insiders
4 insiders reported holding 90,073 shares in total, about $491.3K at the last price.
| Holder | Shares |
|---|---|
| Rossetti AngelaDirector | 26,207 |
| Broenniman Edward GDirector | 22,363 |
| Shah ChetanDirector | 20,840 |
| Gikakis NicolasDirector | 20,663 |
Questions about AEMD
What does Aethlon Medical Inc do?
Aethlon Medical Inc is a company in the Health care sector, listed on NASDAQ as AEMD. Its shares trade on NASDAQ under the ticker AEMD.
What is Aethlon Medical Inc's net worth?
Aethlon Medical Inc has a market value (market cap) of $3.9M at the latest share price, and shareholders' equity of $5.2M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Aethlon Medical Inc profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $6.9M.
When did Aethlon Medical Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the shareholder vote results from October 5, 2026.
When is Aethlon Medical Inc's next earnings report?
Aethlon Medical Inc's next report is expected around November 13, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare AEMD with
Follow AEMD
Get an email when Aethlon Medical Inc files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Aethlon Medical Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.